← Back to Search

Soft Tissue Graft

Markman Biologics Microsurfaced ADM for Gum Recession

Phase 4
Waitlist Available
Research Sponsored by McGuire Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 180 days
Awards & highlights

Study Summary

This study is evaluating whether a new type of eye drop may help reduce the symptoms of dry eye disease.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~180 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 180 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
To compare graft healing at post-op day 14 between Markman Biologics Microsurfaced ADM (Active) and AlloDerm ADM (Control) as assessed by color
Erectile dysfunction
To compare graft healing at post-op day 14 between Markman Biologics Microsurfaced ADM (Active) and AlloDerm ADM (Control) as assessed by graft loss
+2 more
Secondary outcome measures
Assessment of Infection through 180 days
Change in Probing depths
Gingivitis
+7 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: A-ActiveExperimental Treatment1 Intervention
Markman Biologics microsurfaced ADM
Group II: B-ControlActive Control1 Intervention
AlloDerm ADM
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Markman Biologics Microsurfaced ADM
2020
Completed Phase 4
~10

Find a Location

Who is running the clinical trial?

McGuire InstituteLead Sponsor
5 Previous Clinical Trials
308 Total Patients Enrolled
Markman Biologics CorporationIndustry Sponsor
1 Previous Clinical Trials
20 Total Patients Enrolled
Rick Heard, DDSStudy DirectorThe McGuire Institute
1 Previous Clinical Trials
50 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Pilot Study for Healing and Safety Outcomes in Gingival Recession
2020. "Pilot Study for Healing and Safety Outcomes in Gingival Recession". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04614350.
~2 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top